Menu
Washingtoner
  • Home
  • Health
  • Boeing
  • Aerospace
  • Daryl Guberman
  • Technology
  • Business
  • ANSI-ANAB
  • Lifestyle
Washingtoner

Stuart Therapeutics, Inc. Announces Upcoming Presentations at ARVO 2024
Washingtoner/10255123

Trending...
  • Triple-Digit Growth, OTCQX Market Upgrade and a Rapidly Expanding Specialty Healthcare Platform: Cardiff Lexington Corporation: Stock Symbol: CDIX
  • Mutant-Fueled Bio-Cyberpunk Shooter HoverGrease 2 Launches May 22
  • Joseph Nybyk (AKA Joseph Neibich) Guests On Octopus TV
STUART, Fla., April 19, 2024 ~ Stuart Therapeutics, Inc., a clinical-stage ophthalmic biopharmaceutical company, is making strides in the development of therapies for various eye disorders. The company's President and CEO, Eric Schlumpf, will be presenting their latest research results at two upcoming meetings in early May.

On Friday, May 3rd, Schlumpf will be speaking at the Dry Horizons Symposium, co-sponsored by Ora, Inc. His presentation will focus on Stuart Therapeutics' innovative dry eye disease program, which is currently in a Phase 3 trial. The following day, Saturday May 4th, he will be presenting the company's latest pre-clinical results in retinitis pigmentosa and exudative retinal indications at the Ophthalmology Innovation Source (OIS) Retina Meeting.

Both of these meetings will take place at the Four Seasons Hotel in Seattle, Washington. This provides an opportunity for Stuart Therapeutics to showcase their groundbreaking research to a wide audience of industry professionals.

More on Washingtoner
  • Tacoma: Applicants Sought for the Transportation Commission
  • Tacoma: Update Homicide Investigation – Arrest – 1200 block of South M Street
  • Tacoma: Homicide Investigation – 1200 block of South M Street
  • Buzzblender Announces Launch of Simple Hotel Mode for Android and Upcoming Video Wall Support for Samsung Professional Displays
  • How Strategic WooCommerce Development and Digital Marketing Helped a Fashion Ecommerce Business Increase Revenue by 3X

In addition to Schlumpf's presentations, members of Stuart Therapeutics' R&D team have also co-authored a poster presentation that will be presented by researchers from the University of Rochester at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting from May 5-9, 2024. The poster presentation titled "Scleral collagen remodeling and repair assessed in intact eyes through Second Harmonic Generation" focuses on work done at the University of Rochester using Stuart Therapeutics' proprietary collagen mimetic peptide platform. This research aims to understand its effectiveness in reversing scleral collagen disruption in the eye, which is believed to contribute to myopia.

The study authors include Aldo Tecse, Kaitlin Wozniak, James German, Alex McMullen, Mark Buckley, Robert Baratta, Eric Schlumpf, Brian J. Del Buono, Michael Telias and Susana Marcos. This collaboration between Stuart Therapeutics and the University of Rochester highlights the company's commitment to advancing the field of ophthalmology and finding new treatments for eye disorders.

Stuart Therapeutics' presence at these upcoming meetings demonstrates their dedication to innovation and their potential to make a significant impact in the field of ophthalmology. With their cutting-edge research and promising results, they are poised to become a leader in developing therapies for anterior segment, refractive, and posterior segment eye disorders.
Show All News | Disclaimer | Report Violation

0 Comments
1000 characters max.

Latest on Washingtoner
  • KRE PRIME Launches Adaptive Convertible Jumpsuit
  • USA Med Bed Helping Home Care Patients with Refurbished Hill Rom Hospital Beds
  • Sobreseimiento de Nicolás dos Santos y Jorge Méndez expone demandas millonarias a Paraguay y boicot a la Hidrovía
  • CAPHRA warns Southeast Asia not to repeat Australia's nicotine policy failure
  • Milo3D.ai Launches Free AI 3D Model Generator That Turns Text and Images Into Game-Ready 3D Assets in Seconds
  • UK Financial Ltd Executes 100% Success Rate on All ERC-3643 Transfers to Coin Holders of MayaCat Regulated Security Token and Maya Preferred PRA
  • City of Tacoma Observes Memorial Day on May 25
  • Blank Space: The Unofficial Taylor Swift Tribute Brings Eras Tour Magic To Cities Across America
  • Love Must Be the Guide: Live Good Shares a Message of Humanity, Compassion and Hope
  • D.R. Crotzer Announces A New Science Fiction Book Series Exploring Life Energy, Dreams, and the Mystery of Existence
  • Spokane: SPD is Seeking Public's Assistance in Locating Dangerous Offender
  • Spokane: Flags to be Lowered for Memorial Day
  • Color Card Administrator Highlights Growing Enterprise Demand for Operational Infrastructure in Business Card Identity Governance
  • American Properties Celebrates Grand Opening and Ribbon Cutting Ceremony at Heritage at South
  • Crosswalk Ministries USA Announces 2026 Child and Family Well-Being Conference in Stockbridge, Georgia
  • Research reveals "The Borderless Pay Standard," a 48-point gap between multinational employers and workers on transparent pay expectations
  • Global.ai Appoints Freedomtech Solutions as Specialist Partner for Agentic AI
  • Spokane: SPD Involved in a Use of Deadly Force on North Cincinnati St
  • Spokane Police, Urban Native Organizations Sign MOU to Strengthen Relationships and Communication
  • Tacoma: Murder Arrest Made in Connection to April Missing Person Investigation
_catLbl0 _catLbl1

Popular on Washingtoner

  • Altruvest and Financial Executives International Canada Announce Strategic Partnership to Strengthen Nonprofit Boards Across Canada
  • Umbrella Becomes First FinOps Platform to Support AWS Billing Transfer Onboarding
  • Virginia Moving Company Nearly Doubles Customer Calls in Two Weeks After Switching to CARL — the Bold New Alternative to WordPress
  • Spokane AI Expert Adam Chronister to Discuss Authority Engineering at AI Roundtable Event
  • RAS AP Consulting Advances to RFP Stage in Heidelberg Materials' SAP Vendor & Customer Master Data Modernization Initiative
  • Applicants Sought for the Tacoma Creates Advisory Board
  • Resident Inspect Joins Property Meld Nexus Network with API Integration
  • Outlier Pest Season Hits Willamette Valley as Mild Winter Drives Early Surge in Ant and Rodent Activity
  • New plusOne Research Finds the Orgasm Gap Is a 30-Point Chasm — and Confirms It Isn't Biology
  • Lokal Media House Wins Web Excellence Award for Black Plumbing Redesign

Similar on Washingtoner

  • KRE PRIME Launches Adaptive Convertible Jumpsuit
  • Sobreseimiento de Nicolás dos Santos y Jorge Méndez expone demandas millonarias a Paraguay y boicot a la Hidrovía
  • UK Financial Ltd Executes 100% Success Rate on All ERC-3643 Transfers to Coin Holders of MayaCat Regulated Security Token and Maya Preferred PRA
  • Global.ai Appoints Freedomtech Solutions as Specialist Partner for Agentic AI
  • Triple-Digit Growth, OTCQX Market Upgrade and a Rapidly Expanding Specialty Healthcare Platform: Cardiff Lexington Corporation: Stock Symbol: CDIX
  • XRPPower Continues Strengthening Its Global AI-Powered Blockchain Ecosystem
  • Advanced AI Capabilities Reflected by Upcoming Company Name and Stock Symbol Change for Evolving Pre-Owned Boat Dealer: Off The Hook YS: N Y S E: OTH
  • AI-Driven Defense Expansion, Autonomous Systems and Israeli Aerospace Manufacturing Platform: VisionWave Holdings (N A S D A Q: VWAV)
  • Raymond Lavine, Extended Care Benefits Advisor and Author, to Appear on National Television Series Moving America Forward
  • AI Is Closing the Gap Between Offshore Virtual Assistants and Onshore Staff
Copyright © 2026 washingtoner.com | Terms of Service | Privacy Policy | Contact Us | Contribute